- Release Date: 30/09/21 09:21
- Summary: Zantrene highly effective in Melanoma preclinical study
- Price Sensitive: Yes
- Download Document 827.42KB
- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene highly effective in Melanoma preclinical study
Ann: Zantrene highly effective in Melanoma preclinical study
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
-0.025(1.56%) |
Mkt cap ! $272.6M |
Open | High | Low | Value | Volume |
$1.69 | $1.69 | $1.55 | $425.8K | 264.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4500 | $1.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.62 | 3588 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4500 | 1.595 |
1 | 157 | 1.590 |
1 | 5412 | 1.570 |
1 | 1200 | 1.565 |
2 | 2875 | 1.560 |
Price($) | Vol. | No. |
---|---|---|
1.620 | 3588 | 1 |
1.625 | 2500 | 1 |
1.650 | 11485 | 2 |
1.655 | 1069 | 1 |
1.680 | 1830 | 1 |
Last trade - 12.14pm 30/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online